World Hepatitis Day — July 28, 2019

Article Metrics
Altmetric:
Citations:
Views:

Views equals page views plus PDF downloads

Related Materials

World Hepatitis Day, observed each year on July 28, was established to raise awareness and promote understanding of viral hepatitis around the world. The theme of this year’s World Hepatitis Day is “Invest in Eliminating Hepatitis,” underscoring the need to increase commitment for hepatitis response. In 2015, an estimated 257 million persons were living with hepatitis B and 71 million with hepatitis C worldwide (1).

Persons who inject drugs are at highest risk for hepatitis C virus (HCV) infection. Globally, an estimated 15.6 million persons aged 15–64 years inject drugs, 52% of whom are HCV-antibody positive (2). This issue of MMWR features a report on the progress in the country of Georgia toward prevention and detection of HCV infection, and linkage to treatment, of persons with HCV infection who inject drugs (3). Georgia’s hepatitis C elimination program, launched in 2015, was recently named the world’s first Centre of Excellence in Viral Hepatitis Elimination by the European Association for the Study of the Liver International Liver Foundation. Access to hepatitis C testing and treatment for persons who inject drugs is critical to achieving elimination in countries where persons who inject drugs account for a significant proportion of HCV infection. Additional information and resources about viral hepatitis are available at https://www.cdc.gov/hepatitis.


References

  1. World Health Organization. Global hepatitis report, 2017. Geneva, Switzerland: World Health Organization; 2017. https://apps.who.int/iris/bitstream/10665/255016/1/9789241565455-eng.pdf?ua=1pdf iconexternal icon
  2. Degenhardt L, Peacock A, Colledge S, et al. Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review. Lancet Glob Health 2017;5:e1192–207. CrossRefexternal icon PubMedexternal icon
  3. Stvilia K, Spradling PR, Asatiani A, et al. Progress in testing for and treatment of hepatitis C virus infection among persons who inject drugs—Georgia, 2018. MMWR Morb Mortal Wkly Rep 2019;68:637–41.

Suggested citation for this article: World Hepatitis Day — July 28, 2019. MMWR Morb Mortal Wkly Rep 2019;68:637. DOI: http://dx.doi.org/10.15585/mmwr.mm6829a1external icon.

MMWR and Morbidity and Mortality Weekly Report are service marks of the U.S. Department of Health and Human Services.
Use of trade names and commercial sources is for identification only and does not imply endorsement by the U.S. Department of Health and Human Services.
References to non-CDC sites on the Internet are provided as a service to MMWR readers and do not constitute or imply endorsement of these organizations or their programs by CDC or the U.S. Department of Health and Human Services. CDC is not responsible for the content of pages found at these sites. URL addresses listed in MMWR were current as of the date of publication.

All HTML versions of MMWR articles are generated from final proofs through an automated process. This conversion might result in character translation or format errors in the HTML version. Users are referred to the electronic PDF version (https://www.cdc.gov/mmwr) and/or the original MMWR paper copy for printable versions of official text, figures, and tables.

Questions or messages regarding errors in formatting should be addressed to mmwrq@cdc.gov.

View Page In:pdf icon
Page last reviewed: July 25, 2019